Emergence of OXA-48-like Carbapenemase-Producing Escherichia coli in Baranya County, Hungary
<b>Background</b>: Carbapenem-resistant <i>Escherichia coli</i> (CREC) producing OXA-48-like carbapenemase was first detected in Hungary in 2022. The aim of the present study was to characterize such strains isolated in 2022-2025 in Baranya County, Hungary. <b>Methods</b>: Antibiotic susceptibility and the whole-genome sequence (WGS) of <i>E. coli</i> isolates, identified as OXA-48-like carbapenemase producers using the CARBA-5 NG test, were established. The transferability of <i>bla</i><sub>OXA-48-like</sub> plasmids was tested by conjugation. <b>Results</b>: Of the 6722 non-repeat <i>E. coli</i> isolates, 6 produced an OXA-48-like carbapenemase. They exhibited variable resistance to ertapenem and were susceptible to imipenem and meropenem. WGS revealed that all OXA-48-like producer <i>E. coli</i> belonged to high-risk clones: two clonally related OXA-181-producer <i>E. coli</i> ST405 were isolated in Hospital A, three OXA-244-producing <i>E. coli</i> ST38 (two identical via cgMLST from Hospital B), and an OXA-48-producing <i>E. coli</i> ST69. The <i>bla</i><sub>OXA-48</sub> and <i>bla</i><sub>OXA-244</sub> genes were chromosomally located, while <i>bla</i><sub>OXA-181</sub> was on a non-conjugative IncFIB-IncFIC plasmid. So far, the <i>bla</i><sub>OXA-181</sub>-bearing plasmid of this incompatibility type has only been described in Ghana, but all <i>bla</i><sub>OXA-48-like</sub> gene-carrying transposons in this study have already been identified in Europe and other continents. The <i>E. coli</i> ST38 isolates, showing close association based on core genome SNP distances to European and Qatari strains, belonged to Cluster A and harbored <i>bla</i><sub>CTX-M-27.</sub> All but the <i>E. coli</i> ST69 isolate had cephalosporinase gene(s). <b>Conclusions</b>: This study describes small-scale intra-hospital transfers of OXA-48-like carbapenemase-producer <i>E. coli</i>. Interestingly, <i>E. coli</i> ST405 of Hungary carried <i>bla</i><sub>OXA-181</sub> on an IncFIB-IncFIC plasmid, which has only been reported from Africa so far.
Authors
- Levente Laczko
- Edit Urbán (ORCID: https://orcid.org/0000-0002-9602-7552)
- Réka Meszéna
- Szilvia Melegh (ORCID: https://orcid.org/0000-0003-1016-6066)
- Mohamed Al-Bulushi
- Péter Urbán (ORCID: https://orcid.org/0000-0003-4043-3428)
- Csongor Freytag
- Adrienn Nyúl
- Bálint Timmer
- Gábor Kardos (ORCID: https://orcid.org/0000-0002-0554-3130)
- Ágnes Sonnevend (ORCID: https://orcid.org/0000-0002-7065-1736)
- Attila Gyenesei
- László Miló
- Tibor Pál
- Fatma A. Mohamed
- Renáta Bőkényné-Tóth
Institutions
- University of Debrecen (HU)
- Zagazig University (EG)
- University of Pecs (HU)
Publication Details
- Journal
- Antibiotics
- Published
- 2026-01-02
- DOI
- https://doi.org/10.3390/antibiotics15010044
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pécsi Tudományegyetem
- NIH Clinical Center